年龄对哮喘儿童临床特征、药物管理与急性发作的影响
结果显示不同年龄组临床特征、发作率和危险因素不同,5-8岁发作率最高(13.7/100人年),延迟诊断与各年龄段发作增加相关,提示指南应细化年龄分层。
要点
- 5-8岁哮喘儿童急性发作率最高(13.7/100人年),高于9-11岁(10.0)和青少年(6.7)。
- 5-8岁组湿疹、食物/药物过敏和咳嗽比例最高,青少年组超重/肥胖、气传过敏原致敏和呼吸困难比例最高。
- 延迟诊断在5-8岁组最常见,且与所有年龄段发作增加相关。
核心结论
- 儿童哮喘的基线特征和急性发作率因诊断年龄组而异,临床指南应比5-16岁宽泛范围更细致地考虑诊断时年龄。
研究设计与样本
- 采用多变量Cox比例风险模型分析急性发作相关因素。
主要发现
- 5-8岁组湿疹、食物/药物过敏和咳嗽比例最高,青少年组超重/肥胖、气传过敏原致敏、呼吸困难和仅使用短效β2受体激动剂比例最高。
- 急性发作率(每100人年,95%CI):5-8岁=13.7(13.4-13.9),9-11岁=10.0(9.8-10.4),青少年=6.7(6.5-7.0)。
- 5-8岁组发作危险因素中男性、湿疹和食物/药物过敏关联强;≥9岁组肥胖和气传过敏原致敏关联强。
- 所有儿童中,更高的社会经济剥夺与急性发作显著相关。
- 延迟诊断在5-8岁组最常见,且与所有年龄段发作增加相关。
临床怎么用
- 对5-8岁哮喘儿童应关注湿疹、食物/药物过敏等共病,并警惕延迟诊断带来的发作风险。
- 对9岁及以上儿童应重视肥胖和气传过敏原致敏的评估与管理。
- 临床管理应考虑诊断时年龄分层,而非统一按5-16岁宽泛范围处理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Asthma trials and guidelines often do not distinguish between adolescents and younger children. Using a large English data set, we evaluated the impact of age on asthma characteristics, management and exacerbations. METHODS: Primary care medical records, 2004-2021, were linked to hospital records. Children were categorised by age at diagnosis and followed until the next age bracket. Ages (based on management guidelines) were 5-8 years, 9-11 years and adolescents (12-16 years). Characteristics evaluated included body mass index, allergies and events before and after diagnosis (symptoms, medication). Exacerbation incidence was calculated. Multivariable Cox proportional hazards determined associations with exacerbations. RESULTS: 119 611 children were eligible: 61 940 (51.8%) 5-8 years, 32 316 (27.7%) 9-11 years and 25 355 (21.2%) adolescents. Several characteristics differed by age; children aged 5-8 years had the highest proportion with eczema, food/drug allergy and cough, but adolescents had the highest proportion with overweight/obesity, aeroallergen sensitisation, dyspnoea and short-acting-beta-agonist only use. Exacerbation rates were highest in the youngest children (per 100 person-years (95% CI): 5-8 years =13.7 (13.4-13.9), 9-11 years =10.0 (9.8-10.4), adolescents =6.7 (6.5-7.0)). Exacerbation risk factors also differed by age; 5-8 years: male, eczema and food/drug allergy were strongly associated, but for children ≥9 years old, obesity and aeroallergen sensitisation were strongly associated. For all children, higher socioeconomic deprivation was significantly associated with having an exacerbation. Delayed diagnosis was most common in children aged 5-8 years and was associated with increased exacerbations across all ages. CONCLUSION: Children's baseline characteristics and exacerbation rates varied according to their age group. Clinical guidelines should consider age at time of diagnosis more discretely than the broad range, 5-16 years, as this appears to impact on asthma severity and management.
引用
- Khalaf, Bush, Saglani, et al. Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma. Thorax. 2024. PMID: 38071524. doi:10.1136/thorax-2023-220603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。